Loading...
|
Please use this identifier to cite or link to this item:
https://nccur.lib.nccu.edu.tw/handle/140.119/54844
|
| Title: | 我國生醫產業初次上市櫃公開說明書之資訊揭露程度對初級市場承銷定價效率暨次級市場投資人信念異質性之影響
The effects of disclosure level of IPO Prospectus on pricing efficiency and divergence of opinion for biotechnology companies in Taiwan |
| Authors: | 陳韻涵
Chen, Fabienne Y. |
| Contributors: | 蘇瓜藤
Su, Robert K.
陳韻涵
Chen, Fabienne Y. |
| Keywords: | 初次公開發行
生醫產業
資訊揭露程度
事前不確定性
異質信念程度
initial public offering
biotechnology
disclosure level
ex ante uncertainty
divergence of opinion |
| Date: | 2011 |
| Issue Date: | 2012-10-30 13:58:32 (UTC+8) |
| Abstract: | 本研究旨在探討我國生醫產業公開說明書之資訊揭露程度對初次公開發行 (IPO, initial public offering)定價效率及次級市場投資人信念異質性程度之影響。當初級市場認購人間資訊不對稱程度越大時，IPO價值之事前不確定性越高。為均衡各交易參與者之利益，發行人與承銷商將主動提升公開說明書之資訊揭露程度，以制定適當的IPO折價幅度、維持承銷商合理的承銷風險與報酬，並協助認購人適切評定IPO之價值。異質信念觀點強調次級市場投資人對企業價值看法之歧異程度越大，將導致IPO蜜月期報酬之異常現象。本研究預期若無形資產密集度越高，IPO事前不確定性越大，則IPO折價幅度越大，並預期公開說明書之資訊揭露程度將改變無形資產密集度對折價幅度之影響程度。此外，本研究預期，生醫產業IPO案件之無形資產密集度、公開說明書之資訊揭露程度及者配售情形均可能影響投資人信念異質性，進而影響掛牌初期之成交價量表現。
本研究參考國外證券主管機關之無形資產資訊揭露規範，自行建立資訊揭露指標，系統性地衡量我國生醫產業公開說明書之資訊揭露程度，並以多元迴歸分析檢測假說。實證結果顯示，我國生醫產業IPO案件之無形資產密集度對IPO折價幅度存在顯著正向影響；公開說明書之資訊揭露程度改變無形資產密集度對折價幅度之影響程度；發行人之無形資產密集度、公開說明書資訊揭露程度及初級市場配售情形皆影響掛牌初期之投資人信念異質性及價格震盪幅度。研究結果證實公開說明書之資訊揭露提供預期效益，及初級與次級市場間之資訊相互流通、交易行為相互連動之關聯性。
This research examines how the disclosure level of prospectus influences the efficiency of IPO (initial public offering) pricing in the primary market and the degree of divergence of opinions in the secondary market. The literature of IPO underpricing suggests that ex ante uncertainty due to information asymmetry has a positive impact on IPO discount and voluntary disclosure of prospectuses may reduce the uncertainty level. This research hypothesizes that, for biotechnology companies, a greater disclosure level of prospectuses would lower the impact of intensity of intangibles on IPO discount. Further, this research hypothesizes a relation between the pricing efficiency in primary market and the level of divergence of opinions in secondary market.
The empirical results from regression analyses of hand-collected data show that, for biotechnology IPOs, the disclosure level of prospectuses reduces the impact of the intensity of intangibles on IPO discount. In addition, the intensity of intangibles, disclosure level of prospectuses, and trading behaviors in the primary market have an effect on the degree of divergence of opinions in the secondary market. In sum, this research evidences the expected benefits of the increased level of voluntary disclosure of prospectuses for biotechnology IPOs. |
| Reference: | 周行一與呂東英，改善我國現行承銷制度研究報告，中華民國公司組織研究發展協會，2002年7月。
黃蘭霙，承銷新制對資本市場的影響，證券暨期貨月刊，第23卷第6期，2005 年6 月。
諸葛祺、彭桂星、溫鵬榮與張文毅，我國與中國大陸、香港、新加坡、日本及美國證券承銷制度比較分析研究，台灣證券交易所，1998年11月。
龔怡傳，我國有價證券承銷制度暨承銷商法律責任之探討，國立政治大學法律學系研究所學士後法學組碩士論文，2006年3月。
Akerlof, G. A. 1970. The market for “Lemons”: Quality uncertainty and the market mechanism. The Quarterly Journal of Economics 84(3): 488-500.
Allen, F., and Faulhaber, G. R. 1989. Signaling by underpricing in the IPO market. Journal of Financial Economics. 23(2): 303-323.
Amhud, Y., S. Hauser, and A. Kirsh. 2001, Allocation, adverse selection, and cascades in IPOs: Evidence from Israel, working paper, New York University.
Australia Securities Exchange, and AusBiotech. 2005. Code of Best Practice for reporting by life science companies.
Beatty, R. P., and J. R. Ritter. 1986. Investment banking, reputation, and the underpricing of initial public offerings. Journal of Financial Economics 15: 213-232.
Beatty, R. P., and I. Welch. 1996. Issuer expenses and legal liability in initial public offerings. Journal of Law and Economics 39 (2): 545-602.
Bennett, S., R. Parkes, and M. Herrmann. 2004. Biotech valuation: An investor’s guide.
Benveniste, L. M. and P. A. Spindt, 1989, How investment bankers determine the offer price and allocation of new issues, Journal of Financial Economics 24(2): 343-361.
Booth, J. R. and R. Smith, 1986, Capital Raising, Underwriting and the Certification Hypothesis, Journal of Financial Economics 15: 261-281.
Botoson, C. A., 1997. Disclosure level and the cost of equity capital. The Accounting Review 72(3): 323-350.
Bower, N. L. 1984. Firm value and choice of offering method in initial public offerings. Journal of Finance 44(3): 647-662.
Bratic, V. W., P. Tilton, and M. Balakrishnan. 2000. Navigating through biotech valuation. Journal of Biotechnology in Healthcare Research and Regulation 4: 1-7.
Brennan, M. J. and J. Franks, 1997, Underpricing, ownership and control in initial public offerings of equity securities in the UK, Journal of Financial Economics 45(3): 391-413.
Brown G. W., and M. T. Cliff. 2004. Investor sentiment and the near-term stock market, Journal of Empirical Finance 11(1): 1-27.
Burkart, M., D. Gromb, and F. Panunzi, 1997, Large shareholders, monitoring and the value of the firm, Quaterly Journal Economics 112(3): 693-728.
Carter, R. B. and S. Manaster, 1990, Initial public offerings and underwriter reputation, Journal of Finance 45(4): 1045-1067.
Chalk, A. and J. Peavy, 1987, Initial public offering, daily returns, offering types, and the price effect, Financial Analyst Journal 43: 431-453.
Choi, W. W., S. S. Kwon, and G. J. Lobo. 2000. Market valuation of intangible assets. Journal of Business Research 49: 35-45.
Drake, P., and Vetsuypens, M., 1993. IPO underpricing and insurance against legal liability. Financial Management 22: 64-73.
Dunbar ,C. G. 2000. Factors affecting investment bank initial public offering market share, Journal of Financial Economics 55(1): 3-41.
Griliches, Z. 1981. Market value, R&D, and patents. Economics Letters 7: 183-187.
Grinblatt, M. and C.Y. Hwang, 1989, Signaling and the pricing of new issues, Journal of Finance 44(2): 393-420.
Habib, M. A. and A. P. Ljungqvist, 1998, Underpricing and IPO proceeds: A note, Economic Letters 61(3): 381-383.
Hall, B. H. 1993. The stock market`s valuation of R&D investment during the 1980`s. American Economic Review 83(2): 259-264.
Harrington, S. E., and A. B. Miller. 2009. Cost of capital for pharmaceutical, biotechnology, and medicine device firms.
Healy, P., A. Hutton, and K. Palepu. 1999. Stock performance and intermediation changes surrounding sustained increase in disclosure. Contemporary Accounting Research 16: 485-520.
Houge, T., T. Loughran, G. Suchanek, and X. Yan. 2001. Divergence of opinion, uncertainty, and the quality of initial public offerings. Financial Management 30 (4): 5-23.
Hughes, P. J. and A. V. Thakor, 1992, Litigation risk, intermediation, and the underpricing of initial public offerings, Review of Financial Studies 5: 709-742.
Ibbotson, R. G., 1975, Price performance of common stock new issues, Journal of Financial Economics 2(3): 235-272.
Institutional Shareholders’ Committee. 2002. Suggested Disclosure of Research and Development Expenditure.
Jain, B.A., and O. Kini. 1994. The post-issue operating performance of IPO firms. Journal of Finance 49(5): 1699-1726.
Jefferey J. Stewart. 2002. Biotechnology Valuations for The 21st Century.
Jens, P. J. 2007. Valuation Models for Australian Biotechnology Companies. RMIT University.
Krigman, L., W. H. Shaw, and K. L. Womack. 1997. The persistence of IPO mispricing and the predictive power of flipping. The Journal of Finance 54: 1015-1044.
Kumar, A., and M. C. C. Lee. 2006. Retail investor sentiment and return comovements, Journal of Finance, American Finance Association 61(5): 2451-2486.
Lang, M. and R. Lundolm. 1993. Cross-sectional determinants of analysts rating of corporate disclosure. Journal of Accounting Research 31: 246-271.
Lang, M. and R. Lundolm. 1997. Voluntary disclosure during equity offering: Reducing information asymmetry or hyping the stock? Working Paper, University of Michigan.
Mcguinness, P. 1992. An examination of the underpricing of initial public offerings in Hong Kong: 1980-90. Journal of Business Finance and accounting 19(2): 165-187.
Megna, P. and M. Klock. 1993. The impact of intangible capital on Tobin’s q in the semiconductor industry. American Economic Review 83: 265-269.
Michaely, R. and W. H. Shaw, 1992, Asymmetric Information, Adverse Selection, and the Pricing of Initial Public Offerings, mimeo, Cornell University.
Miller, E. M. 1977. Risk, uncertaint, and divergence of opinions. The Journal of Finance 32 (September): 1151-1166.
Miller, G. 1999. Earnings performance and discretionary disclosure. Working Paper, Harvard University.
Miller, G., and J. Piotroski. 2000. The Role of Disclosure for High Book-to-market Firms. Working Paper. Harvard University.
Megginson, W. L., and K. A. Weiss. 1991. Venture capitalist certification in initial public offerings, Journal of Finance 46(3): 879-903.
Nanda, V., and Y. Yun. 1997. Reputation and financial intermediation: An empirical investigation of the impact of IPO mispricing on underwriter market value. Journal of Financial Intermediation 6(1): 39-63.
Ritter, J. R. 1984. The hot issue market in 1980. Journal of Business. 57(2): 215-241.
Ritter, J. R., 1991, The long-run performance of initial public offerings. Journal of Finance 46(1): 3-26.
Rock, K. 1986. Why new issues are underpriced. Journal of Financial Economics 15: 187-212.
Spence, A. M. ,1974, Market Signaling, Cambridge, Mass: Harvard University Press.
Stoughton, N. M. and J. Zechnoer, 1998, IPO mechanisms, monitoring and ownership structure, Journal of Financial Economics 49(1): 45-78.
Tinic, S. M., 1988, Anatomy of Initial Public Offerings of Common Stock, Journal of Finance 43(4): 789-822.
Welch, I., 1989, Seasoned offerings, imitation costs, and the underpricing of initial public offerings, Journal of Finance 44(2): 421-449.
Welch, I., 1992, Sequential sales, learning, and cascades, Journal of Finance 47: 659-732.
Welch, I., 1996, Equity offerings following the IPO: Theory and evidence, Journal of Corporate Finance 2(3): 227-259. |
| Description: | 碩士
國立政治大學
會計研究所
99353012
100 |
| Source URI: | http://thesis.lib.nccu.edu.tw/record/#G0993530121 |
| Data Type: | thesis |
| Appears in Collections: | [會計學系] 學位論文
|
Files in This Item:
| File |
Size | Format | |
|---|
| 012101.pdf | 1933Kb | Adobe PDF2 | 1041 | View/Open |
|
All items in 政大典藏 are protected by copyright, with all rights reserved.
|
